GTR 119123457
Bids Are Invited For Pembrolizumab 100 Mg4ml Sol Iny Fam Nivolumab 10Mgml Sol.Iny. Iv Fam 10Ml Atezolizumab 1200 Mg Sol Pperf Fam Nivolumab 10Mgml Sol Iny Iv Fam 4 Ml 1000023181
ICB — International Competitive Bid
Closes Nov 10, 2026
South America
Tender Information
GTR Reference
119123457
Tendering Authority
Subscribe to view
Tender No
621-918-LR26
Financer Name
Self-Funded
Work Title
Bids Are Invited For Pembrolizumab 100 Mg4ml Sol Iny Fam Nivolumab 10Mgml Sol.Iny. Iv Fam 10Ml Atezolizumab 1200 Mg Sol Pperf Fam Nivolumab 10Mgml Sol Iny Iv Fam 4 Ml 1000023181
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
South America
Political Region
Asia-Pacific Economic Cooperation, APEC,APAC (Asia Pacific)
Last Date of Bid Submission
10-11-2026
Work Detail
Type Administrative And Technical Bases, By Which The Tender Processes Will Be Governed For The Acquisition Of Pharmaceutical Products, Cosmetics, Vaccines, Supplies, Devices, And/Or Food For Medical Use, Intended For The Exercise Of Health Actions
Key Value
Tender Value
5,088,222,182 - CLP
Tender Documents
Global Tender Document
d4d33556-1091-4688-9650-a6622dcce074.html
Attachments
Additional Details Available on Click
- Tendering Authority
- Publication Document (Tender Document / Tender Notice)
Disclaimer
We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.